RaySearch Laboratories AB (OTCPK:RSLBF)

Q4 2025 RaySearch Laboratories AB (publ) Earnings Call Transcript

Feb 12, 2026 / 10:00 AM GMT

Release Date Price: $23

Transcript

Key Points

Positve

RaySearch Laboratories AB (RSLBF) achieved record high net sales in Q4 2025, growing by 16% to 375 million Swedish crowns.
The company reported a 25% increase in operating profit for Q4, reaching 92 million Swedish crowns, with a margin of 24%.
For the full year 2025, net sales increased by 13% to 1.34 billion Swedish crowns, marking the highest annual revenue in the company's history.
RaySearch Laboratories AB (RSLBF) continues to see strong momentum with license sales to both new and existing customers across all regions.
The company has made significant clinical progress, including the world's first clinical proton arc treatments, which was recognized as one of the top 10 scientific breakthroughs of the year by Physics World.

Negative

Currency headwinds negatively impacted the company's financial results, with adjusted growth figures showing a higher potential growth rate.
The order backlog has decreased, partly due to currency effects, which could be a concern for future revenue growth.
There are challenges in the seamless implementation of online adaptive radiotherapy without the full integration of RayCare.
The Pinnacle conversion rate was lower than expected in Q4, indicating potential challenges in converting existing clinics.
Administrative costs remained high in Q4, raising questions about cost management despite the absence of extraordinary costs in that quarter.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RAYb.ST - RaySearch Laboratories AB (publ)
Q4 2025 RaySearch Laboratories AB (publ) Earnings Call
Feb 12, 2026 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
A warm welcome to Research 2025 year and results presentation. My name is Carolina Stemblit, and I'm head of investor relations. With me today are our CEO and founder, Johan Lou and our CFO Nina Grombey, who will take you through the key highlights and financial results.

After the presentation, we will open up for questions. Feel free to submit them in the Q&A chat or ask them live. With that said, CNY, over to you.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Carolina, and welcome again, everyone.

So this is the agenda

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.